Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-80,382
Closed -$4.05M 3362
2015
Q4
$4.05M Buy
80,382
+27,877
+53% +$1.41M 0.07% 184
2015
Q3
$2.47M Buy
52,505
+5,345
+11% +$284K 0.04% 337
2015
Q2
$2.56M Sell
47,160
-15,615
-25% -$876K 0.05% 342
2015
Q1
$3.44M Sell
62,775
-17,921
-22% -$1.01M 0.07% 197
2014
Q4
$4.37M Sell
80,696
-1,782
-2% -$99.3K 0.07% 172
2014
Q3
$4.67M Sell
82,478
-33,326
-29% -$1.87M 0.09% 158
2014
Q2
$6.39M Sell
115,804
-37,204
-24% -$2.03M 0.1% 126
2014
Q1
$8.29M Buy
153,008
+44,750
+41% +$2.32M 0.1% 142
2013
Q4
$5.17M Buy
108,258
+44,959
+71% +$2.06M 0.06% 231
2013
Q3
$2.88M Buy
+63,299
New +$2.89M 0.04% 419

Other funds holding MRK

Virtu KCG Holdings's MRK Position: Q2 2017 in Review

Virtu KCG Holdings increased its Merck (MRK) stake by 580% in Q2 2017, buying an estimated $6.68M and bringing the position to 128,662 shares worth $7.87M. The position accounts for 0.22% of the portfolio, ranked #31.

Virtu KCG Holdings first reported a position in MRK in Q3 2013 and has held it in 15 quarters since. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Virtu KCG Holdings held 128,662 shares of Merck worth $7.87M as of Q2 2017.
  • Virtu KCG Holdings bought 109,746 Merck shares in Q2 2017, an estimated $6.68M.
  • Merck made up 0.22% of Virtu KCG Holdings's portfolio in Q2 2017, its #31 holding.
  • Virtu KCG Holdings first reported a position in Merck in Q3 2013 and has held it in 15 quarters since.
  • 1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.